Ben McLaughlin

Healthcare & Life Sciences

• Advised a leading private equity firm on its acquisition of i-Med Network, one of the world’s largest medical imaging clinic groups, for over AUD 500 million.
• Counseled Reckitt Benckiser on the reorganisation and spin-off of its pharmaceutical division.
• Advised Baxter Healthcare on the reorganisation and spin-off of its biopharma division.
• Counseled Ramsay Health Care on its AUD 500 million joint venture in Asia with Sime Darby.
• Advised Hospira on its AUD 2.7 billion takeover of Mayne Pharma, Australia’s largest healthcare M&A transaction.
• Counseled Sonic Healthcare on the AUD 400 million acquisition of Clinical Pathology Laboratories.

Japanese M&A

• Advised Mitsubishi UFJ Trust and Banking Corporation on its AUD 4.13 billion acquisition of Colonial First State Global Asset Management from Commonwealth Bank.
• Advised Bunka Shutter Co., Ltd. on its AUD 50-100 million acquisition of ArcPac Garage Doors from Crescent Capital Partners.
• Advised Japan Pulp and Paper Co., Ltd. on its AUD 75 million acquisition of a 51% interest in a newly formed entity, known as PagePack. PagePack comprises BJ Ball and the KW Doggett groups in Australia and New Zealand.
• Advised Daiwa House Industry Co., Ltd on its AUD 300-400 million acquisition of the Rawson Group.
• Advised Recruit Holdings on its AUD 350 million acquisition of Chandlers Macleod (scheme of arrangement).
• Advised Recruit Holdings on its AUD 150 million acquisition of Peoplebank.

• Key individual for Corporate/M&A in Australia, Chambers Asia Pacific
• Notable practitioner for Life Sciences in Asia Pacific, Chambers Asia Pacific
• Recognised as "Lawyer of the Year" for Life Sciences Practice in Sydney, 2022, Best Lawyers
• Also recognised as one of the Best Lawyers in Australia for Corporate/Corporate Governance and Mergers and Acquisitions Law, Best Lawyers 2022 Edition

• American Chamber of Commerce - Health Committee
• Australian Institute of Company Directors - Law Committee

• Chicago